Skip to main content
. 2016 Aug 3;17(3):1470320316652047. doi: 10.1177/1470320316652047

Figure 3.

Figure 3.

(a) Fixed and (b) random model forest plots of the effect of angiotensin-converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) therapy vs placebo to prevent microalbuminuria in type 2 diabetes.